Sleep disorders after COVID-19 in Czech population: Post-lockdown national online survey
Status PubMed-not-MEDLINE Language English Country Netherlands Media electronic-ecollection
Document type Journal Article
PubMed
37811367
PubMed Central
PMC10551886
DOI
10.1016/j.sleepx.2023.100087
PII: S2590-1427(23)00027-7
Knihovny.cz E-resources
- Keywords
- Dream-enactment behaviour, Long COVID, Nightmare, Parasomnia, Post-COVID syndrome, Prevalence, SARS-CoV-2,
- Publication type
- Journal Article MeSH
OBJECTIVE: This study aimed to determine the frequency, type, and correlates of a broad spectrum of sleep disorders in adults with COVID-19 up to 32 months after infection. METHODS: We conducted a national online survey (Jun 2021-Dec 2022), gathering information on COVID-19 diagnosis, acute disease course, and the subsequent development of sleep disorders from 1507 respondents (mean age 44.5 ± 13.1 years, 64.1% women). RESULTS: 81.3% (1223) reported at least one sleep difficulty that either worsened or first appeared with COVID-19. Females reported a higher number of symptoms (2.03 ± 1.44 versus 1.72 ± 1.43 in men, p < 0.0001). Most common were insomnia symptoms (59.4%), followed by night sweats (38.4%), hypersomnolence (33.3%), vivid dreams or nightmares (26.4%), restless leg syndrome (RLS) (22.8%), and sleep-related breathing disorders (11.1%). All symptoms were associated with a more severe acute disease. A mild decreasing trend in the persistence of sleep symptoms with a longer latency since infection was observed, with 66.7% reporting at least half of their symptoms present at 3-5 months after acute infection, compared to 64.9% at 6-8 months, and 62.4% at 9-11 months (p = 0.0427). However, among those after 12 or more months, over half of the symptoms persisted in 69.5%. The frequency of vivid dreams and nightmares increased in association with COVID-19 in 32.9% (p < 0.001). 9.4% (141) reported new-onset or increased parasomnic manifestations after the infection. CONCLUSIONS: Our research shows that sleep disturbances are a common and persistent manifestation of COVID-19 that affects a large proportion of the population and deserves careful monitoring.
See more in PubMed
Di Carlo D.T., Montemurro N., Petrella G., Siciliano G., Ceravolo R., Perrini P. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature. J Neurol. 2021;268(5):1561–1569. doi: 10.1007/s00415-020-09978-y. PubMed DOI PMC
Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127. PubMed DOI PMC
Paterson R.W., Brown R.L., Benjamin L., et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104–3120. doi: 10.1093/brain/awaa240. PubMed DOI PMC
Ousseiran Z.H., Fares Y., Chamoun W.T. Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int J Neurosci. 2021;27:1–16. doi: 10.1080/00207454.2021.1973000. Published online September. PubMed DOI PMC
Carfì A., Bernabei R., Landi F. For the gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi: 10.1001/jama.2020.12603. PubMed DOI PMC
Liguori C., Pierantozzi M., Spanetta M., et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020;88:11–16. doi: 10.1016/j.bbi.2020.05.037. PubMed DOI PMC
Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8. PubMed DOI PMC
Alimoradi Z., Broström A., Tsang H.W.H., et al. Sleep problems during COVID-19 pandemic and its' association to psychological distress: a systematic review and meta-analysis. EClinicalMedicine. 2021;36 doi: 10.1016/j.eclinm.2021.100916. PubMed DOI PMC
Partinen M., Holzinger B., Morin C.M., et al. Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire. BMJ Open. 2021;11(12) doi: 10.1136/bmjopen-2021-050672. PubMed DOI PMC
Pinto J., van Zeller M., Amorim P., et al. Sleep quality in times of COVID-19 pandemic. Sleep Med. 2020;74:81–85. doi: 10.1016/j.sleep.2020.07.012. PubMed DOI PMC
Akbarialiabad H., Taghrir M.H., Abdollahi A., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163–1186. doi: 10.1007/s15010-021-01666-x. PubMed DOI PMC
World Health Organization . 2022. Post COVID-19 condition (long COVID). World health organization europe.https://www.who.int/europe/news-room/fact-sheets/item/post-COVID-19-condition Published December 7.
Postuma R.B., Arnulf I., Hogl B., et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov. Disord. Off. J. Mov. Disord. Soc. 2012;27(7):913–916. doi: 10.1002/mds.25037. PubMed DOI PMC
Fränkl E., Scarpelli S., Nadorff M.R., et al. How our dreams changed during the COVID-19 pandemic: effects and correlates of dream recall frequency - a multinational study on 19,355 adults. Nat Sci Sleep. 2021;13:1573–1591. doi: 10.2147/NSS.S324142. PubMed DOI PMC
Ellul M.A., Benjamin L., Singh B., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–783. doi: 10.1016/S1474-4422(20)30221-0. PubMed DOI PMC
Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019. PubMed DOI PMC
Jahrami H., BaHammam A.S., Bragazzi N.L., Saif Z., Faris M., Vitiello M.V. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med. 2021;17(2):299–313. doi: 10.5664/jcsm.8930. PubMed DOI PMC
Musse F.C.C., Castro L. de S., Sousa K.M.M., et al. Mental violence: the COVID-19 nightmare. Front Psychiatr. 2020;11 doi: 10.3389/fpsyt.2020.579289. PubMed DOI PMC
Deng J., Zhou F., Hou W., et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90–111. doi: 10.1111/nyas.14506. PubMed DOI PMC
Merikanto I., Dauvilliers Y., Chung F., et al. Sleep symptoms are essential features of long-COVID - comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II) J Sleep Res. 2023;32(1) doi: 10.1111/jsr.13754. PubMed DOI PMC
Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631. doi: 10.1038/s41591-021-01292-y. PubMed DOI PMC
Asadi-Pooya A.A., Akbari A., Emami A., et al. Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. 2021;46(6):428–436. doi: 10.30476/ijms.2021.92080.2326. PubMed DOI PMC
Alimoradi Z., Gozal D., Tsang H.W.H., et al. Gender-specific estimates of sleep problems during the COVID-19 pandemic: systematic review and meta-analysis. J Sleep Res. 2022;31(1) doi: 10.1111/jsr.13432. PubMed DOI PMC
Neculicioiu V., Colosi I., Costache C., Sevastre-Berghian A., Clichici S. Time to sleep? - a review of the impact of the COVID-19 pandemic on sleep and mental health. Int J Environ Res Publ Health. 2022;19:3497. doi: 10.3390/ijerph19063497. PubMed DOI PMC
Cénat J.M., Blais-Rochette C., Kokou-Kpolou C.K., et al. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: a systematic review and meta-analysis. Psychiatr Res. 2021;295 doi: 10.1016/j.psychres.2020.113599. PubMed DOI PMC
Liu Y., Partinen E., Chan N.Y., et al. Dream-enactment behaviours during the COVID-19 pandemic: an international COVID-19 sleep study. J Sleep Res. 2023;32(1) doi: 10.1111/jsr.13613. PubMed DOI PMC
Alzueta E., Perrin P.B., Yuksel D., et al. An international study of post-COVID sleep health. Sleep Health. 2022;8(6):684–690. doi: 10.1016/j.sleh.2022.06.011. PubMed DOI PMC
Alkodaymi M.S., Omrani O.A., Fawzy N.A., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2022;28(5):657–666. doi: 10.1016/j.cmi.2022.01.014. PubMed DOI PMC
Salfi F., Amicucci G., Corigliano D., et al. Two years after lockdown: longitudinal trajectories of sleep disturbances and mental health over the COVID-19 pandemic, and the effects of age, gender and chronotype. J Sleep Res. 2022;1 doi: 10.1111/jsr.13767. Published online November. PubMed DOI PMC
Lam M.H.B., Wing Y.K., Yu M.W.M., et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142–2147. doi: 10.1001/archinternmed.2009.384. PubMed DOI
Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathog. Basel Switz. 2022;11(2) doi: 10.3390/pathogens11020269. PubMed DOI PMC
Fang H., Tu S., Sheng J., Shao A. Depression in sleep disturbance: a review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019;23(4):2324–2332. doi: 10.1111/jcmm.14170. PubMed DOI PMC
COG-CZ - Česká Republika. Linie SARS-CoV-2 Detekované v Česku. COG-CZ - Česká Republika https://virus.img.cas.cz/lineages..
Nyberg T., Ferguson N.M., Nash S.G., et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet Lond Engl. 2022;399(10332):1303–1312. doi: 10.1016/S0140-6736(22)00462-7. PubMed DOI PMC